At present, no AAV gene therapy product has been approved for marketing for hemophilia in China and globally. This registrational clinical study ( ...
https://www.google.com/url?rct=j&sa=t&url=https://eturbonews.com/3013451/first-subject-receives-new-drug-therapy-for-hemophilia-b/&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNECp2d3BYFKByBgr0G9iNiBzn-UcQ
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.